Two Sigma Securities, LLC Moderna, Inc. Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $2.44 Million - $4.81 Million	38,400 Added 44.7%	124,300 $8.31 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $2.27 Million - $3.73 Million	22,400 Added 35.28%	85,900 $10.2 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $2.27 Million - $3.07 Million	-26,600 Reduced 29.52%	63,500 $6.77 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.74 Million - $4.11 Million	39,400 Added 77.71%	90,100 $8.96 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $8.46 Million - $11.1 Million	-87,800 Reduced 63.39%	50,700 $5.24 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $13.9 Million - $18.8 Million	117,200 Added 550.23%	138,500 $16.8 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $271,320 - $394,040	-2,000 Reduced 8.58%	21,300 $3.27 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $7.01 Million - $12.4 Million	-59,200 Reduced 71.76%	23,300 $4.19 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $3.86 Million - $6.35 Million	-32,700 Reduced 28.39%	82,500 $9.76 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $10.8 Million - $16.2 Million	92,000 Added 396.55%	115,200 $16.5 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $2.61 Million - $4.84 Million	20,600 Added 792.31%	23,200 $4 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.55 Million - $5.79 Million	-15,700 Reduced 85.79%	2,600 $660,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $2.15 Million - $4.7 Million	9,700 Added 112.79%	18,300 $7.04 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $454,685 - $822,430	3,500 Added 68.63%	8,600 $2.02 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $335,274 - $866,286	5,100 New	5,100 $533,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account